| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 1.34e-05 | 30 | 31 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 1.34e-05 | 30 | 31 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | mRNA binding | 6.04e-04 | 694 | 31 | 6 | GO:0003729 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.61e-03 | 562 | 31 | 5 | GO:0003712 | |
| GeneOntologyBiologicalProcess | mRNA processing | FIP1L1 CDK11A ACIN1 SNRNP48 SAFB SREK1 CDK11B SNW1 LUC7L3 PQBP1 CPSF6 CDK13 LUC7L2 SNRNP35 DHX8 CPSF7 PHRF1 | 2.64e-19 | 551 | 31 | 17 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | FIP1L1 CDK11A ACIN1 SNRNP48 SAFB SREK1 CDK11B SNW1 LUC7L3 PQBP1 CPSF6 CDK13 LUC7L2 SNRNP35 DHX8 CPSF7 PHRF1 | 1.32e-15 | 917 | 31 | 17 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA processing | FIP1L1 CDK11A ACIN1 SNRNP48 SAFB SREK1 CDK11B SNW1 LUC7L3 PQBP1 CPSF6 CDK13 DROSHA LUC7L2 SNRNP35 DHX8 CPSF7 PHRF1 | 2.43e-13 | 1500 | 31 | 18 | GO:0006396 |
| GeneOntologyBiologicalProcess | RNA splicing | ACIN1 SNRNP48 SREK1 SNW1 LUC7L3 PQBP1 CDK13 LUC7L2 SNRNP35 DHX8 | 1.87e-09 | 502 | 31 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.24e-08 | 358 | 31 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.24e-08 | 358 | 31 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.62e-08 | 362 | 31 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.15e-07 | 158 | 31 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 2.12e-05 | 36 | 31 | 3 | GO:0007064 | |
| GeneOntologyBiologicalProcess | mRNA alternative polyadenylation | 3.27e-05 | 6 | 31 | 2 | GO:0110104 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.43e-05 | 443 | 31 | 6 | GO:1903311 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 4.47e-05 | 46 | 31 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion, centromeric | 4.57e-05 | 7 | 31 | 2 | GO:0071962 | |
| GeneOntologyBiologicalProcess | co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway | 7.82e-05 | 9 | 31 | 2 | GO:0180010 | |
| GeneOntologyBiologicalProcess | co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway | 9.76e-05 | 10 | 31 | 2 | GO:0180012 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 1.38e-04 | 67 | 31 | 3 | GO:0007062 | |
| GeneOntologyBiologicalProcess | centromeric sister chromatid cohesion | 1.97e-04 | 14 | 31 | 2 | GO:0070601 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 2.59e-04 | 16 | 31 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | RNA 3'-end processing | 4.24e-04 | 98 | 31 | 3 | GO:0031123 | |
| GeneOntologyBiologicalProcess | chromosome organization | 4.79e-04 | 686 | 31 | 6 | GO:0051276 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 9.89e-04 | 31 | 31 | 2 | GO:0051291 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FIP1L1 ACIN1 MSH6 SNRNP48 SREK1 SNW1 LUC7L3 NIPBL CPSF6 CDK13 DROSHA BCLAF1 LUC7L2 SNRNP35 DHX8 CPSF7 | 1.35e-11 | 1377 | 31 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear speck | ACIN1 SREK1 SNW1 LUC7L3 PQBP1 PSPC1 CPSF6 CDK13 BCLAF1 LUC7L2 YLPM1 | 1.47e-11 | 431 | 31 | 11 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear body | ACIN1 SREK1 SNW1 LUC7L3 PQBP1 PSPC1 CPSF6 CDK13 BCLAF1 LUC7L2 DHX8 YLPM1 | 2.59e-09 | 903 | 31 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | spliceosomal complex | 2.35e-08 | 215 | 31 | 7 | GO:0005681 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 1.95e-06 | 61 | 31 | 4 | GO:0000307 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 7.50e-06 | 26 | 31 | 3 | GO:0005847 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.25e-05 | 97 | 31 | 4 | GO:0005684 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.29e-05 | 31 | 31 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 7.61e-05 | 9 | 31 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 8.23e-05 | 157 | 31 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | paraspeckles | 9.51e-05 | 10 | 31 | 2 | GO:0042382 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.12e-04 | 170 | 31 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 2.68e-04 | 1194 | 31 | 8 | GO:1990904 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 3.21e-04 | 18 | 31 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 3.21e-04 | 18 | 31 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 3.21e-04 | 18 | 31 | 2 | GO:0071010 | |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 5.76e-04 | 24 | 31 | 2 | GO:0032806 | |
| GeneOntologyCellularComponent | U12-type spliceosomal complex | 9.02e-04 | 30 | 31 | 2 | GO:0005689 | |
| GeneOntologyCellularComponent | U2-type catalytic step 2 spliceosome | 9.64e-04 | 31 | 31 | 2 | GO:0071007 | |
| GeneOntologyCellularComponent | U1 snRNP | 1.09e-03 | 33 | 31 | 2 | GO:0005685 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.45e-03 | 335 | 31 | 4 | GO:0061695 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 3.12e-03 | 56 | 31 | 2 | GO:0008023 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 8.90e-03 | 96 | 31 | 2 | GO:0097525 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 9.08e-03 | 97 | 31 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 1.10e-02 | 107 | 31 | 2 | GO:0030532 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 1.34e-02 | 119 | 31 | 2 | GO:0120114 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.82e-02 | 140 | 31 | 2 | GO:0016363 | |
| MousePheno | small face | 3.33e-05 | 37 | 24 | 3 | MP:0030064 | |
| MousePheno | abnormal face size | 4.89e-05 | 42 | 24 | 3 | MP:0030063 | |
| MousePheno | increased skin tumor incidence | 6.02e-05 | 45 | 24 | 3 | MP:0010300 | |
| Domain | RRM | 4.21e-08 | 217 | 30 | 7 | SM00360 | |
| Domain | RRM_dom | 5.73e-08 | 227 | 30 | 7 | IPR000504 | |
| Domain | - | 9.39e-08 | 244 | 30 | 7 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.37e-07 | 258 | 30 | 7 | IPR012677 | |
| Domain | RRM_1 | 8.43e-07 | 208 | 30 | 6 | PF00076 | |
| Domain | RRM | 1.52e-06 | 230 | 30 | 6 | PS50102 | |
| Domain | LUC7 | 7.48e-06 | 3 | 30 | 2 | PF03194 | |
| Domain | Luc7-rel | 7.48e-06 | 3 | 30 | 2 | IPR004882 | |
| Domain | - | 5.14e-04 | 21 | 30 | 2 | 1.10.720.30 | |
| Domain | SAP | 5.65e-04 | 22 | 30 | 2 | PF02037 | |
| Domain | SAP | 6.18e-04 | 23 | 30 | 2 | SM00513 | |
| Domain | SAP | 7.31e-04 | 25 | 30 | 2 | PS50800 | |
| Domain | SAP_dom | 7.31e-04 | 25 | 30 | 2 | IPR003034 | |
| Domain | Guanylate_kin | 7.91e-04 | 26 | 30 | 2 | PF00625 | |
| Domain | GuKc | 7.91e-04 | 26 | 30 | 2 | SM00072 | |
| Domain | GK/Ca_channel_bsu | 7.91e-04 | 26 | 30 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 7.91e-04 | 26 | 30 | 2 | IPR008144 | |
| Domain | WW | 2.58e-03 | 47 | 30 | 2 | PF00397 | |
| Domain | WW | 2.69e-03 | 48 | 30 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 3.03e-03 | 51 | 30 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 3.03e-03 | 51 | 30 | 2 | PS01159 | |
| Domain | WW_dom | 3.15e-03 | 52 | 30 | 2 | IPR001202 | |
| Domain | P-loop_NTPase | 1.06e-02 | 848 | 30 | 5 | IPR027417 | |
| Domain | Ser/Thr_kinase_AS | 1.92e-02 | 357 | 30 | 3 | IPR008271 | |
| Domain | S_TKc | 1.95e-02 | 359 | 30 | 3 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.99e-02 | 362 | 30 | 3 | PS00108 | |
| Domain | Pkinase | 2.28e-02 | 381 | 30 | 3 | PF00069 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | FIP1L1 ACIN1 SNRNP48 SNW1 LUC7L3 PQBP1 CPSF6 SNRNP35 DHX8 CPSF7 | 3.63e-11 | 283 | 26 | 10 | M13087 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 8.95e-10 | 277 | 26 | 9 | MM15414 | |
| Pathway | REACTOME_MRNA_SPLICING | 8.13e-08 | 212 | 26 | 7 | M14033 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | FIP1L1 ACIN1 SNRNP48 SNW1 LUC7L3 PQBP1 CPSF6 SNRNP35 DHX8 CPSF7 | 3.01e-07 | 724 | 26 | 10 | M16843 |
| Pathway | REACTOME_METABOLISM_OF_RNA | 8.31e-07 | 612 | 26 | 9 | MM15547 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.42e-06 | 201 | 26 | 6 | MM15411 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 6.22e-06 | 20 | 26 | 3 | MM15469 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 6.22e-06 | 20 | 26 | 3 | M497 | |
| Pathway | WP_MRNA_PROCESSING | 1.27e-05 | 451 | 26 | 7 | MM15946 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.97e-05 | 29 | 26 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.97e-05 | 29 | 26 | 3 | MM15444 | |
| Pathway | KEGG_SPLICEOSOME | 8.05e-05 | 127 | 26 | 4 | M2044 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.96e-04 | 62 | 26 | 3 | MM15426 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.47e-04 | 67 | 26 | 3 | M27694 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 3.50e-03 | 48 | 26 | 2 | MM15410 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 3.79e-03 | 50 | 26 | 2 | M5583 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FIP1L1 ACIN1 MSH6 SNRNP48 SAFB SREK1 CDK11B SNW1 LUC7L3 PSPC1 NIPBL CPSF6 DROSHA BCLAF1 LUC7L2 DHX8 YLPM1 CPSF7 | 9.14e-20 | 1082 | 31 | 18 | 38697112 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FIP1L1 ACIN1 SAFB SREK1 CDK11B SNW1 LUC7L3 PSPC1 CPSF6 CDK13 DROSHA BCLAF1 LUC7L2 DHX8 YLPM1 CPSF7 | 1.33e-18 | 807 | 31 | 16 | 22681889 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ANKRD11 FIP1L1 CDK11A ACIN1 SAFB SREK1 CDK11B SNW1 LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 YLPM1 CPSF7 | 1.86e-17 | 954 | 31 | 16 | 36373674 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 9.58e-15 | 154 | 31 | 9 | 16055720 | |
| Pubmed | FIP1L1 ACIN1 SNRNP48 SAFB CDK11B SNW1 LUC7L3 CPSF6 BCLAF1 CPSF7 | 1.24e-14 | 251 | 31 | 10 | 31076518 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.14e-14 | 283 | 31 | 10 | 30585729 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | FIP1L1 ACIN1 MSH6 SREK1 SNW1 LUC7L3 NIPBL CPSF6 LUC7L2 DHX8 YLPM1 CPSF7 | 4.55e-14 | 582 | 31 | 12 | 20467437 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ANKRD11 FIP1L1 ACIN1 SAFB SNW1 LUC7L3 PQBP1 NIPBL CDK13 BCLAF1 LUC7L2 DHX8 YLPM1 CPSF7 PHRF1 | 5.75e-14 | 1294 | 31 | 15 | 30804502 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | FIP1L1 CDK11A ACIN1 SREK1 LUC7L3 CPSF6 CDK13 DROSHA BCLAF1 LUC7L2 SNRNP35 DHX8 | 3.68e-13 | 695 | 31 | 12 | 23602568 |
| Pubmed | FIP1L1 ACIN1 MSH6 SAFB SREK1 CDK11B LUC7L3 CPSF6 BCLAF1 SNRNP35 DHX8 CPSF7 | 4.97e-13 | 713 | 31 | 12 | 29802200 | |
| Pubmed | FIP1L1 SNRNP48 SREK1 SNW1 SRRM3 PQBP1 PSPC1 CPSF6 CDK13 LUC7L2 DHX8 CPSF7 | 5.85e-13 | 723 | 31 | 12 | 34133714 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FIP1L1 ACIN1 MSH6 SAFB SREK1 CDK11B SNW1 LUC7L3 CPSF6 BCLAF1 LUC7L2 YLPM1 CPSF7 | 9.44e-13 | 989 | 31 | 13 | 36424410 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.07e-12 | 259 | 31 | 9 | 30404004 | |
| Pubmed | FIP1L1 ACIN1 MSH6 SAFB CDK11B SNW1 PQBP1 PSPC1 NIPBL CDK13 BCLAF1 YLPM1 CPSF7 | 1.29e-12 | 1014 | 31 | 13 | 32416067 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.41e-12 | 163 | 31 | 8 | 22113938 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FIP1L1 ACIN1 SAFB SNW1 LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 DHX8 YLPM1 CPSF7 | 1.46e-12 | 1024 | 31 | 13 | 24711643 |
| Pubmed | FIP1L1 ACIN1 CDK11B SNW1 LUC7L3 PQBP1 PSPC1 CPSF6 CDK13 DROSHA BCLAF1 LUC7L2 YLPM1 CPSF7 | 2.90e-12 | 1371 | 31 | 14 | 36244648 | |
| Pubmed | FIP1L1 ACIN1 SAFB SREK1 SNW1 LUC7L3 PSPC1 DROSHA BCLAF1 LUC7L2 DHX8 CPSF7 | 3.72e-12 | 847 | 31 | 12 | 35850772 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACIN1 MSH6 SAFB SREK1 SNW1 LUC7L3 PSPC1 NIPBL CPSF6 BCLAF1 LUC7L2 VPS35 DHX8 CPSF7 | 4.86e-12 | 1425 | 31 | 14 | 30948266 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FIP1L1 CDK11A ACIN1 MSH6 SAFB CDK11B NIPBL CDK13 BCLAF1 YLPM1 PHRF1 | 3.49e-11 | 774 | 31 | 11 | 15302935 |
| Pubmed | FIP1L1 CDK11A ACIN1 SAFB PQBP1 PSPC1 CPSF6 BCLAF1 DHX8 CPSF7 PHRF1 | 4.11e-11 | 786 | 31 | 11 | 29128334 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 5.29e-11 | 148 | 31 | 7 | 32538781 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | FIP1L1 ACIN1 MSH6 SAFB CDK11B SNW1 LUC7L3 BCLAF1 LUC7L2 YLPM1 | 7.53e-11 | 605 | 31 | 10 | 28977666 |
| Pubmed | ANKRD11 CDK11A MSH6 SREK1 MAN1A2 PQBP1 PSPC1 NIPBL CPSF6 CDK13 DROSHA DHX8 PHRF1 | 1.65e-10 | 1497 | 31 | 13 | 31527615 | |
| Pubmed | 4.13e-10 | 506 | 31 | 9 | 30890647 | ||
| Pubmed | 8.51e-10 | 220 | 31 | 7 | 24550385 | ||
| Pubmed | 8.71e-10 | 551 | 31 | 9 | 34728620 | ||
| Pubmed | 1.35e-09 | 55 | 31 | 5 | 27114453 | ||
| Pubmed | FIP1L1 MSH6 SAFB SNW1 PQBP1 PSPC1 NIPBL CPSF6 CDK13 BCLAF1 CPSF7 | 1.47e-09 | 1103 | 31 | 11 | 34189442 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.66e-09 | 130 | 31 | 6 | 35545047 | |
| Pubmed | 1.75e-09 | 399 | 31 | 8 | 35987950 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 2.03e-09 | 607 | 31 | 9 | 39147351 | |
| Pubmed | Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. | 2.56e-09 | 4 | 31 | 3 | 29276085 | |
| Pubmed | Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. | 3.19e-09 | 65 | 31 | 5 | 18729074 | |
| Pubmed | 3.83e-09 | 653 | 31 | 9 | 33742100 | ||
| Pubmed | 3.93e-09 | 655 | 31 | 9 | 35819319 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ANKRD11 FIP1L1 ACIN1 SNW1 LUC7L3 PSPC1 CPSF6 BCLAF1 YLPM1 CPSF7 | 4.37e-09 | 922 | 31 | 10 | 27609421 |
| Pubmed | 4.42e-09 | 153 | 31 | 6 | 28225217 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 5.64e-09 | 289 | 31 | 7 | 23752268 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FIP1L1 CDK11A SAFB CDK11B LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 DHX8 | 5.75e-09 | 949 | 31 | 10 | 36574265 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACIN1 MSH6 SAFB SREK1 CDK11B SNW1 LUC7L3 PSPC1 NIPBL CPSF6 LUC7L2 | 9.35e-09 | 1318 | 31 | 11 | 30463901 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 9.72e-09 | 497 | 31 | 8 | 36774506 | |
| Pubmed | ANKRD11 MSH6 SAFB SREK1 SNW1 PQBP1 NIPBL CDK13 VPS35 YLPM1 CPSF7 | 1.00e-08 | 1327 | 31 | 11 | 32694731 | |
| Pubmed | 1.02e-08 | 731 | 31 | 9 | 29298432 | ||
| Pubmed | 1.07e-08 | 503 | 31 | 8 | 16964243 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MSH6 SNW1 LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 CDK13 LUC7L2 VPS35 DHX8 | 1.94e-08 | 1415 | 31 | 11 | 28515276 |
| Pubmed | ACIN1 SNRNP48 SAFB SREK1 CLCN5 PSPC1 NIPBL CDK13 BCLAF1 VPS35 YLPM1 | 2.36e-08 | 1442 | 31 | 11 | 35575683 | |
| Pubmed | 2.61e-08 | 206 | 31 | 6 | 22174317 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.86e-08 | 220 | 31 | 6 | 35785414 | |
| Pubmed | 7.18e-08 | 419 | 31 | 7 | 15635413 | ||
| Pubmed | 7.30e-08 | 245 | 31 | 6 | 35652658 | ||
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 7.85e-08 | 248 | 31 | 6 | 27926873 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 9.17e-08 | 665 | 31 | 8 | 30457570 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MAGI1 ACIN1 MSH6 SREK1 CDK11B LUC7L3 CPSF6 BCLAF1 LUC7L2 VPS35 | 9.92e-08 | 1284 | 31 | 10 | 17353931 |
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 19884882 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 1.42e-07 | 704 | 31 | 8 | 32994395 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.58e-07 | 714 | 31 | 8 | 28302793 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.77e-07 | 1367 | 31 | 10 | 32687490 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.96e-07 | 486 | 31 | 7 | 30940648 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FIP1L1 CDK11A CDK11B MAN1A2 CLCN5 PSPC1 CPSF6 LUC7L2 VPS35 CPSF7 | 3.08e-07 | 1451 | 31 | 10 | 30550785 |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 3.18e-07 | 162 | 31 | 5 | 31363146 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 4.03e-07 | 170 | 31 | 5 | 16159877 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 4.20e-07 | 330 | 31 | 6 | 33301849 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.35e-07 | 332 | 31 | 6 | 32786267 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.09e-07 | 341 | 31 | 6 | 32971831 | |
| Pubmed | 5.64e-07 | 347 | 31 | 6 | 16033648 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 5.65e-07 | 182 | 31 | 5 | 32239614 | |
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | 5.81e-07 | 183 | 31 | 5 | 28186131 | |
| Pubmed | 6.63e-07 | 188 | 31 | 5 | 29721183 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.76e-07 | 358 | 31 | 6 | 32460013 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 7.10e-07 | 361 | 31 | 6 | 30344098 | |
| Pubmed | 7.40e-07 | 79 | 31 | 4 | 14729942 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 7.45e-07 | 364 | 31 | 6 | 24778252 | |
| Pubmed | Regulated expression of a cell division control-related protein kinase during development. | 7.69e-07 | 2 | 31 | 2 | 2069872 | |
| Pubmed | A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. | 7.69e-07 | 2 | 31 | 2 | 7528743 | |
| Pubmed | Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. | 7.69e-07 | 2 | 31 | 2 | 10882096 | |
| Pubmed | The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. | 7.69e-07 | 2 | 31 | 2 | 27049727 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 1774066 | ||
| Pubmed | Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. | 7.69e-07 | 2 | 31 | 2 | 8195233 | |
| Pubmed | Structure and expression of the human p58clk-1 protein kinase chromosomal gene. | 7.69e-07 | 2 | 31 | 2 | 1639388 | |
| Pubmed | The U1 snRNP-associated factor Luc7p affects 5' splice site selection in yeast and human. | 7.69e-07 | 2 | 31 | 2 | 17726058 | |
| Pubmed | Protein expression pattern of CDK11(p58) during testicular development in the mouse. | 7.69e-07 | 2 | 31 | 2 | 15792358 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 15060143 | ||
| Pubmed | CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization. | 7.69e-07 | 2 | 31 | 2 | 28101846 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 30722725 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 7920654 | ||
| Pubmed | 8.44e-07 | 21 | 31 | 3 | 32731332 | ||
| Pubmed | 9.40e-07 | 1247 | 31 | 9 | 27684187 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.00e-06 | 1257 | 31 | 9 | 36526897 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.20e-06 | 89 | 31 | 4 | 22446626 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.20e-06 | 934 | 31 | 8 | 33916271 | |
| Pubmed | 1.25e-06 | 641 | 31 | 7 | 36057605 | ||
| Pubmed | 1.42e-06 | 653 | 31 | 7 | 22586326 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.48e-06 | 410 | 31 | 6 | 26949251 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.51e-06 | 411 | 31 | 6 | 35182466 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 1.68e-06 | 670 | 31 | 7 | 22990118 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.82e-06 | 678 | 31 | 7 | 30209976 | |
| Pubmed | 2.26e-06 | 441 | 31 | 6 | 31239290 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 15937220 | ||
| Pubmed | Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. | 2.31e-06 | 3 | 31 | 2 | 17389615 | |
| Interaction | DDX23 interactions | ANKRD11 FIP1L1 CDK11A ACIN1 MSH6 SAFB SREK1 SNW1 LUC7L3 CPSF6 CDK13 BCLAF1 DHX8 PHRF1 | 2.87e-15 | 480 | 31 | 14 | int:DDX23 |
| Interaction | DHX8 interactions | FIP1L1 CDK11A SAFB SNW1 LUC7L3 CPSF6 CDK13 BCLAF1 LUC7L2 DHX8 YLPM1 PHRF1 | 7.54e-15 | 292 | 31 | 12 | int:DHX8 |
| Interaction | MECP2 interactions | FIP1L1 ACIN1 MSH6 SNRNP48 SAFB SREK1 CDK11B SNW1 LUC7L3 PSPC1 NIPBL CPSF6 DROSHA BCLAF1 LUC7L2 DHX8 YLPM1 CPSF7 | 2.59e-14 | 1287 | 31 | 18 | int:MECP2 |
| Interaction | DHX40 interactions | ANKRD11 FIP1L1 CDK11A SAFB SNW1 CPSF6 DROSHA BCLAF1 DHX8 YLPM1 CPSF7 | 5.59e-14 | 249 | 31 | 11 | int:DHX40 |
| Interaction | SMC5 interactions | ANKRD11 FIP1L1 CDK11A ACIN1 SAFB SREK1 CDK11B SNW1 LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 YLPM1 CPSF7 | 1.79e-13 | 1000 | 31 | 16 | int:SMC5 |
| Interaction | TOP1 interactions | FIP1L1 ACIN1 MSH6 SNRNP48 SAFB SNW1 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 DHX8 YLPM1 CPSF7 | 4.65e-13 | 696 | 31 | 14 | int:TOP1 |
| Interaction | SRPK2 interactions | FIP1L1 ACIN1 SAFB SREK1 LUC7L3 PSPC1 CPSF6 CDK13 DROSHA BCLAF1 LUC7L2 SNRNP35 DHX8 CPSF7 | 6.95e-13 | 717 | 31 | 14 | int:SRPK2 |
| Interaction | SNRPC interactions | FIP1L1 ACIN1 SAFB SREK1 SNW1 LUC7L3 PQBP1 CPSF6 BCLAF1 DHX8 YLPM1 CPSF7 | 9.80e-13 | 440 | 31 | 12 | int:SNRPC |
| Interaction | SNRPB interactions | ACIN1 SNRNP48 SAFB SNW1 LUC7L3 PQBP1 CPSF6 BCLAF1 SNRNP35 DHX8 YLPM1 CPSF7 | 6.49e-12 | 517 | 31 | 12 | int:SNRPB |
| Interaction | CPSF6 interactions | FIP1L1 ACIN1 SAFB SNW1 PQBP1 PSPC1 CPSF6 BCLAF1 LUC7L2 DHX8 YLPM1 CPSF7 | 7.93e-12 | 526 | 31 | 12 | int:CPSF6 |
| Interaction | OBSL1 interactions | FIP1L1 ACIN1 SAFB SNW1 LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 VPS35 DHX8 YLPM1 CPSF7 | 1.53e-11 | 902 | 31 | 14 | int:OBSL1 |
| Interaction | JMJD6 interactions | 1.62e-11 | 205 | 31 | 9 | int:JMJD6 | |
| Interaction | PRPF40A interactions | FIP1L1 CDK11A ACIN1 SREK1 SNW1 PSPC1 CPSF6 CDK13 DHX8 YLPM1 CPSF7 | 3.14e-11 | 446 | 31 | 11 | int:PRPF40A |
| Interaction | PRP4K interactions | 3.84e-11 | 329 | 31 | 10 | int:PRP4K | |
| Interaction | SNRNP70 interactions | FIP1L1 ACIN1 MSH6 SAFB SREK1 CDK11B SNW1 LUC7L3 CPSF6 BCLAF1 LUC7L2 SNRNP35 DHX8 CPSF7 | 4.87e-11 | 984 | 31 | 14 | int:SNRNP70 |
| Interaction | NUP43 interactions | ANKRD11 ACIN1 SAFB SREK1 CDK11B LUC7L3 PQBP1 NIPBL BCLAF1 LUC7L2 DHX8 PHRF1 | 5.87e-11 | 625 | 31 | 12 | int:NUP43 |
| Interaction | SNIP1 interactions | FIP1L1 ACIN1 SNW1 PSPC1 NIPBL CDK13 BCLAF1 LUC7L2 DHX8 PHRF1 | 3.89e-10 | 417 | 31 | 10 | int:SNIP1 |
| Interaction | SRSF7 interactions | CDK11A ACIN1 SAFB SREK1 SNW1 LUC7L3 CPSF6 BCLAF1 LUC7L2 DHX8 | 4.68e-10 | 425 | 31 | 10 | int:SRSF7 |
| Interaction | RNPS1 interactions | FIP1L1 CDK11A ACIN1 SREK1 CDK11B LUC7L3 CPSF6 LUC7L2 DHX8 CPSF7 | 4.68e-10 | 425 | 31 | 10 | int:RNPS1 |
| Interaction | CSNK2A1 interactions | ANKRD11 FIP1L1 CDK11A ACIN1 MSH6 SAFB SREK1 CDK11B CPSF6 BCLAF1 LUC7L2 CPSF7 PHRF1 | 5.29e-10 | 956 | 31 | 13 | int:CSNK2A1 |
| Interaction | RBM25 interactions | 9.23e-10 | 323 | 31 | 9 | int:RBM25 | |
| Interaction | RAD18 interactions | FIP1L1 ACIN1 SNRNP48 SAFB CDK11B SNW1 LUC7L3 CPSF6 BCLAF1 CPSF7 | 9.44e-10 | 457 | 31 | 10 | int:RAD18 |
| Interaction | MAPKAPK2 interactions | 1.13e-09 | 134 | 31 | 7 | int:MAPKAPK2 | |
| Interaction | SNRNP40 interactions | ACIN1 SREK1 CDK11B SNW1 LUC7L3 PQBP1 CPSF6 BCLAF1 DHX8 CPSF7 PHRF1 | 1.38e-09 | 637 | 31 | 11 | int:SNRNP40 |
| Interaction | SRPK1 interactions | ACIN1 SAFB SREK1 LUC7L3 PSPC1 CPSF6 DROSHA BCLAF1 LUC7L2 DHX8 | 1.43e-09 | 477 | 31 | 10 | int:SRPK1 |
| Interaction | SNRPA interactions | 1.58e-09 | 482 | 31 | 10 | int:SNRPA | |
| Interaction | LUC7L2 interactions | 2.01e-09 | 353 | 31 | 9 | int:LUC7L2 | |
| Interaction | SRSF6 interactions | ACIN1 SREK1 CDK11B SNW1 CPSF6 CDK13 BCLAF1 LUC7L2 DHX8 PHRF1 | 2.38e-09 | 503 | 31 | 10 | int:SRSF6 |
| Interaction | ZC3H18 interactions | FIP1L1 CDK11A ACIN1 SAFB SNW1 LUC7L3 PQBP1 PSPC1 CPSF6 BCLAF1 LUC7L2 DHX8 | 2.81e-09 | 877 | 31 | 12 | int:ZC3H18 |
| Interaction | SSRP1 interactions | ANKRD11 ACIN1 MSH6 SAFB SREK1 SNW1 PQBP1 NIPBL DROSHA BCLAF1 YLPM1 | 2.94e-09 | 685 | 31 | 11 | int:SSRP1 |
| Interaction | SNRPF interactions | 4.29e-09 | 385 | 31 | 9 | int:SNRPF | |
| Interaction | CHD4 interactions | FIP1L1 CDK11A ACIN1 MSH6 SAFB CDK11B SNW1 LUC7L3 BCLAF1 LUC7L2 DHX8 YLPM1 | 5.99e-09 | 938 | 31 | 12 | int:CHD4 |
| Interaction | CIT interactions | MAGI1 FIP1L1 CDK11A ACIN1 MSH6 SAFB SREK1 SNW1 LUC7L3 PSPC1 NIPBL BCLAF1 DHX8 CPSF7 | 7.75e-09 | 1450 | 31 | 14 | int:CIT |
| Interaction | PNN interactions | 1.36e-08 | 302 | 31 | 8 | int:PNN | |
| Interaction | THRAP3 interactions | 1.45e-08 | 443 | 31 | 9 | int:THRAP3 | |
| Interaction | CLK2 interactions | 1.54e-08 | 195 | 31 | 7 | int:CLK2 | |
| Interaction | MEN1 interactions | FIP1L1 ACIN1 SAFB SREK1 SNW1 LUC7L3 PSPC1 CPSF6 DROSHA BCLAF1 DHX8 YLPM1 | 1.69e-08 | 1029 | 31 | 12 | int:MEN1 |
| Interaction | ZRANB2 interactions | 1.77e-08 | 199 | 31 | 7 | int:ZRANB2 | |
| Interaction | RBM39 interactions | ACIN1 SAFB SREK1 SNW1 PQBP1 PSPC1 CPSF6 DROSHA BCLAF1 LUC7L2 DHX8 YLPM1 | 1.94e-08 | 1042 | 31 | 12 | int:RBM39 |
| Interaction | CUL7 interactions | FIP1L1 ACIN1 MSH6 SAFB SNW1 LUC7L3 PSPC1 CPSF6 BCLAF1 CPSF7 PHRF1 | 2.59e-08 | 845 | 31 | 11 | int:CUL7 |
| Interaction | NKAP interactions | 4.53e-08 | 132 | 31 | 6 | int:NKAP | |
| Interaction | XRCC6 interactions | CDK11A ACIN1 MSH6 CDK11B SNW1 PSPC1 CPSF6 BCLAF1 DHX8 YLPM1 PHRF1 | 6.75e-08 | 928 | 31 | 11 | int:XRCC6 |
| Interaction | EED interactions | ACIN1 MSH6 SAFB MAN1A2 LUC7L3 PSPC1 NIPBL CPSF6 DROSHA BCLAF1 VPS35 YLPM1 CPSF7 | 7.62e-08 | 1445 | 31 | 13 | int:EED |
| Interaction | HNRNPA1 interactions | FIP1L1 ACIN1 SAFB SREK1 SNW1 PSPC1 CPSF6 DROSHA BCLAF1 YLPM1 CPSF7 | 8.12e-08 | 945 | 31 | 11 | int:HNRNPA1 |
| Interaction | RBM14 interactions | 9.72e-08 | 553 | 31 | 9 | int:RBM14 | |
| Interaction | SNW1 interactions | 1.01e-07 | 747 | 31 | 10 | int:SNW1 | |
| Interaction | SRSF1 interactions | 1.26e-07 | 570 | 31 | 9 | int:SRSF1 | |
| Interaction | CEBPA interactions | FIP1L1 ACIN1 MSH6 SAFB SNW1 PQBP1 PSPC1 NIPBL CPSF6 CDK13 BCLAF1 CPSF7 | 1.38e-07 | 1245 | 31 | 12 | int:CEBPA |
| Interaction | PPIL4 interactions | 1.71e-07 | 165 | 31 | 6 | int:PPIL4 | |
| Interaction | UFL1 interactions | FIP1L1 CDK11A ACIN1 SNW1 LUC7L3 PSPC1 CPSF6 BCLAF1 LUC7L2 VPS35 CPSF7 | 1.96e-07 | 1031 | 31 | 11 | int:UFL1 |
| Interaction | DOT1L interactions | FIP1L1 ACIN1 SAFB SNW1 LUC7L3 PSPC1 DROSHA LUC7L2 DHX8 CPSF7 | 2.07e-07 | 807 | 31 | 10 | int:DOT1L |
| Interaction | MFAP1 interactions | 2.61e-07 | 295 | 31 | 7 | int:MFAP1 | |
| Interaction | HDLBP interactions | FIP1L1 SNW1 LUC7L3 PSPC1 CPSF6 DROSHA LUC7L2 VPS35 YLPM1 CPSF7 | 3.53e-07 | 855 | 31 | 10 | int:HDLBP |
| Interaction | SRPK3 interactions | 3.93e-07 | 190 | 31 | 6 | int:SRPK3 | |
| Interaction | SART1 interactions | 4.24e-07 | 317 | 31 | 7 | int:SART1 | |
| Interaction | BARD1 interactions | 4.81e-07 | 323 | 31 | 7 | int:BARD1 | |
| Interaction | NSRP1 interactions | 4.86e-07 | 197 | 31 | 6 | int:NSRP1 | |
| Interaction | UHRF2 interactions | 5.31e-07 | 200 | 31 | 6 | int:UHRF2 | |
| Interaction | SRSF11 interactions | 5.79e-07 | 203 | 31 | 6 | int:SRSF11 | |
| Interaction | PRPF6 interactions | 6.27e-07 | 336 | 31 | 7 | int:PRPF6 | |
| Interaction | RNF113A interactions | 6.45e-07 | 692 | 31 | 9 | int:RNF113A | |
| Interaction | ACTC1 interactions | 6.60e-07 | 694 | 31 | 9 | int:ACTC1 | |
| Interaction | DDX42 interactions | 6.68e-07 | 208 | 31 | 6 | int:DDX42 | |
| Interaction | PCF11 interactions | 7.02e-07 | 111 | 31 | 5 | int:PCF11 | |
| Interaction | PRMT1 interactions | FIP1L1 SAFB SNW1 LUC7L3 PSPC1 CPSF6 BCLAF1 LUC7L2 YLPM1 CPSF7 | 7.56e-07 | 929 | 31 | 10 | int:PRMT1 |
| Interaction | TNIP2 interactions | ANKRD11 FIP1L1 ACIN1 SNW1 LUC7L3 PSPC1 CPSF6 BCLAF1 YLPM1 CPSF7 | 9.45e-07 | 952 | 31 | 10 | int:TNIP2 |
| Interaction | CCNT1 interactions | 1.06e-06 | 225 | 31 | 6 | int:CCNT1 | |
| Interaction | FIP1L1 interactions | 1.06e-06 | 225 | 31 | 6 | int:FIP1L1 | |
| Interaction | PPP1CC interactions | 1.10e-06 | 738 | 31 | 9 | int:PPP1CC | |
| Interaction | FBXO22 interactions | 1.16e-06 | 540 | 31 | 8 | int:FBXO22 | |
| Interaction | CHD3 interactions | 1.36e-06 | 757 | 31 | 9 | int:CHD3 | |
| Interaction | LUC7L interactions | 1.61e-06 | 242 | 31 | 6 | int:LUC7L | |
| Interaction | ERH interactions | 1.73e-06 | 245 | 31 | 6 | int:ERH | |
| Interaction | RBM10 interactions | 2.09e-06 | 253 | 31 | 6 | int:RBM10 | |
| Interaction | ATXN1 interactions | ZXDC ACIN1 CDK11B PQBP1 CPSF6 CDK13 BCLAF1 LUC7L2 VPS35 CPSF7 | 2.09e-06 | 1039 | 31 | 10 | int:ATXN1 |
| Interaction | PHRF1 interactions | 2.25e-06 | 61 | 31 | 4 | int:PHRF1 | |
| Interaction | SUPT5H interactions | 2.29e-06 | 408 | 31 | 7 | int:SUPT5H | |
| Interaction | TOX4 interactions | 2.37e-06 | 142 | 31 | 5 | int:TOX4 | |
| Interaction | SNRPD2 interactions | 2.52e-06 | 414 | 31 | 7 | int:SNRPD2 | |
| Interaction | NXF1 interactions | ZXDC MAGI1 SNW1 LUC7L3 CPSF6 DROSHA BCLAF1 VPS35 DHX8 YLPM1 CPSF7 | 2.74e-06 | 1345 | 31 | 11 | int:NXF1 |
| Interaction | SF3A2 interactions | 3.24e-06 | 273 | 31 | 6 | int:SF3A2 | |
| Interaction | MYCN interactions | FIP1L1 CDK11A ACIN1 SAFB SNW1 PQBP1 CPSF6 CDK13 BCLAF1 LUC7L2 CPSF7 | 3.35e-06 | 1373 | 31 | 11 | int:MYCN |
| Interaction | WWOX interactions | 3.51e-06 | 627 | 31 | 8 | int:WWOX | |
| Interaction | HDAC11 interactions | 3.53e-06 | 154 | 31 | 5 | int:HDAC11 | |
| Interaction | RNF2 interactions | 4.11e-06 | 866 | 31 | 9 | int:RNF2 | |
| Interaction | NR2C2 interactions | ACIN1 MSH6 SAFB SREK1 CDK11B SNW1 LUC7L3 PSPC1 NIPBL CPSF6 LUC7L2 | 4.13e-06 | 1403 | 31 | 11 | int:NR2C2 |
| Interaction | ADAR interactions | 4.23e-06 | 286 | 31 | 6 | int:ADAR | |
| Interaction | YLPM1 interactions | 4.26e-06 | 160 | 31 | 5 | int:YLPM1 | |
| Interaction | SUZ12 interactions | 4.28e-06 | 644 | 31 | 8 | int:SUZ12 | |
| Interaction | PRPF38A interactions | 4.39e-06 | 161 | 31 | 5 | int:PRPF38A | |
| Interaction | CELF1 interactions | 4.41e-06 | 288 | 31 | 6 | int:CELF1 | |
| Interaction | U2AF2 interactions | 4.64e-06 | 651 | 31 | 8 | int:U2AF2 | |
| Interaction | BMI1 interactions | 5.07e-06 | 659 | 31 | 8 | int:BMI1 | |
| Interaction | RBMX interactions | 5.12e-06 | 461 | 31 | 7 | int:RBMX | |
| Interaction | SRRM2 interactions | 5.19e-06 | 462 | 31 | 7 | int:SRRM2 | |
| Interaction | EFTUD2 interactions | MSH6 SREK1 SNW1 LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 CDK13 LUC7L2 VPS35 | 5.64e-06 | 1449 | 31 | 11 | int:EFTUD2 |
| Interaction | ACIN1 interactions | 5.68e-06 | 301 | 31 | 6 | int:ACIN1 | |
| Interaction | TXNL4A interactions | 5.73e-06 | 77 | 31 | 4 | int:TXNL4A | |
| Interaction | ZRSR2 interactions | 5.73e-06 | 77 | 31 | 4 | int:ZRSR2 | |
| Interaction | C1orf35 interactions | 6.01e-06 | 304 | 31 | 6 | int:C1orf35 | |
| Cytoband | 1p36.33 | 1.25e-03 | 77 | 31 | 2 | 1p36.33 | |
| Cytoband | 14q24.3 | 1.82e-03 | 93 | 31 | 2 | 14q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 4.00e-03 | 139 | 31 | 2 | chr5p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q24 | 8.08e-03 | 200 | 31 | 2 | chr14q24 | |
| GeneFamily | RNA binding motif containing | 1.59e-07 | 213 | 22 | 6 | 725 | |
| GeneFamily | Cyclin dependent kinases | 3.99e-06 | 26 | 22 | 3 | 496 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.51e-04 | 26 | 22 | 2 | 904 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.02e-02 | 181 | 22 | 2 | 694 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.01e-05 | 432 | 31 | 6 | M41149 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.17e-05 | 680 | 31 | 7 | M41089 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 3.07e-05 | 790 | 31 | 7 | M12490 | |
| Coexpression | GCNP_SHH_UP_EARLY.V1_UP | 5.13e-05 | 174 | 31 | 4 | M2639 | |
| Coexpression | GSE3982_MAST_CELL_VS_DC_UP | 8.64e-05 | 199 | 31 | 4 | M5426 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 8.81e-05 | 200 | 31 | 4 | M5995 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN | 8.81e-05 | 200 | 31 | 4 | M7904 | |
| Coexpression | CHIN_BREAST_CANCER_COPY_NUMBER_DN | 1.05e-04 | 13 | 31 | 2 | M8845 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 1.65e-04 | 714 | 31 | 6 | M1744 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.69e-04 | 237 | 31 | 4 | M15606 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.78e-04 | 240 | 31 | 4 | MM976 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 2.58e-04 | 776 | 31 | 6 | M1107 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 2.92e-04 | 794 | 31 | 6 | MM982 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 3.43e-04 | 523 | 31 | 5 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 3.78e-04 | 534 | 31 | 5 | MM1054 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 3.84e-04 | 294 | 31 | 4 | M41112 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | FIP1L1 MSH6 CACNB2 SNRNP48 SREK1 CDK11B LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 SNRNP35 DHX8 | 6.19e-10 | 1257 | 31 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | FIP1L1 MSH6 CACNB2 SNRNP48 SREK1 CDK11B LUC7L3 PQBP1 PSPC1 NIPBL CPSF6 BCLAF1 SNRNP35 DHX8 | 4.29e-09 | 1459 | 31 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.59e-08 | 259 | 31 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.99e-07 | 532 | 31 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MAGI1 FIP1L1 CACNB2 CDK11B LUC7L3 PSPC1 NIPBL CPSF6 BCLAF1 SNRNP35 DHX8 | 1.97e-06 | 1370 | 31 | 11 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.07e-06 | 469 | 31 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 6.90e-06 | 186 | 31 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.23e-05 | 271 | 31 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 5.17e-05 | 1252 | 31 | 9 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.63e-05 | 298 | 31 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 6.75e-05 | 994 | 31 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 6.75e-05 | 492 | 31 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.11e-05 | 311 | 31 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.58e-04 | 831 | 31 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.68e-04 | 192 | 31 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.58e-04 | 629 | 31 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.81e-04 | 406 | 31 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 4.42e-04 | 983 | 31 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 4.50e-04 | 986 | 31 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 5.80e-04 | 266 | 31 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 6.93e-04 | 1060 | 31 | 7 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 7.14e-04 | 498 | 31 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 8.64e-04 | 790 | 31 | 6 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 8.92e-04 | 795 | 31 | 6 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 9.04e-04 | 797 | 31 | 6 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 9.16e-04 | 799 | 31 | 6 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 9.28e-04 | 801 | 31 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 9.46e-04 | 804 | 31 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 9.58e-04 | 806 | 31 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 1.04e-03 | 819 | 31 | 6 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.43e-03 | 339 | 31 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.58e-03 | 595 | 31 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.74e-03 | 1241 | 31 | 7 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 2.57e-03 | 978 | 31 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 2.68e-03 | 403 | 31 | 4 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 2.72e-03 | 989 | 31 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.80e-09 | 200 | 31 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.37e-07 | 197 | 31 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.49e-07 | 199 | 31 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.55e-07 | 200 | 31 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 4.96e-06 | 164 | 31 | 4 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.51e-06 | 188 | 31 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.24e-06 | 192 | 31 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.43e-06 | 193 | 31 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.00e-05 | 196 | 31 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.04e-05 | 198 | 31 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.04e-05 | 198 | 31 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.06e-05 | 199 | 31 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-05 | 200 | 31 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.19e-04 | 138 | 31 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 2.02e-04 | 165 | 31 | 3 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.05e-04 | 166 | 31 | 3 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.44e-04 | 176 | 31 | 3 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 183 | 31 | 3 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-04 | 185 | 31 | 3 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 187 | 31 | 3 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 188 | 31 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.01e-04 | 189 | 31 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.15e-04 | 192 | 31 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 3.25e-04 | 194 | 31 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.40e-04 | 197 | 31 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.45e-04 | 198 | 31 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.45e-04 | 198 | 31 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.45e-04 | 198 | 31 | 3 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.50e-04 | 199 | 31 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| Disease | infant grey matter volume measurement | 1.62e-04 | 18 | 31 | 2 | EFO_0008368 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.18e-03 | 447 | 31 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 1.32e-03 | 51 | 31 | 2 | EFO_0004869, EFO_0004872 | |
| Disease | breast carcinoma (is_marker_for) | 2.20e-03 | 66 | 31 | 2 | DOID:3459 (is_marker_for) | |
| Disease | susceptibility to hepatitis A infection measurement | 2.33e-03 | 68 | 31 | 2 | EFO_0008415 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERGRERDRRDTKRHS | 1311 | Q9UKV3 | |
| REKWRDEKERHRDRH | 1466 | Q6UB99 | |
| EKEREHERRKRHREE | 126 | P21127 | |
| HERRKRHREEQDKAR | 131 | P21127 | |
| RRKEREARREVSAHH | 201 | P21127 | |
| SGRSKERHREHRRRD | 206 | Q14004 | |
| RHRESRHRSRDVDRE | 601 | Q08289 | |
| NREHERHRDRERDRH | 456 | Q8N684 | |
| KRNREDRASHREREE | 1446 | Q96QZ7 | |
| ERHRASREKEERHRE | 516 | Q6UN15 | |
| SREKEERHRERRHRE | 521 | Q6UN15 | |
| ERHRERRHREKEETR | 526 | Q6UN15 | |
| RRHREKEETRHKSSR | 531 | Q6UN15 | |
| LERKHRHESGDSRER | 866 | Q6KC79 | |
| KHQRERSHERPDRKE | 1136 | Q9P1Y6 | |
| HDRSERKHRSRSRDR | 336 | O95232 | |
| EKRRDEHRRRPDHPD | 376 | P52701 | |
| DKADREEGKERRHHR | 166 | O60828 | |
| EEGKERRHHRREELA | 171 | O60828 | |
| RERSRERDHSRSREK | 491 | Q16630 | |
| ERDHSRSREKSRRHK | 496 | Q16630 | |
| ADLRHDIDRRRKERS | 691 | Q9NYF8 | |
| DWVREKSRDRDRHRE | 91 | P51795 | |
| HARVKEREHERRKRH | 111 | Q9UQ88 | |
| EREHERRKRHREEQD | 116 | Q9UQ88 | |
| KEREARREVSAHHRT | 191 | Q9UQ88 | |
| DEHRHREEEERLRNK | 96 | O60476 | |
| ERNRDRDHKRRHRSR | 191 | Q14562 | |
| EREEREKLRRSRSHS | 251 | Q9Y383 | |
| YERSRERERERHRHR | 281 | Q9NRR4 | |
| ERERERHRHRDNRRS | 286 | Q9NRR4 | |
| HREILDHERKRRVEL | 51 | A6NNA2 | |
| KERDHISERRERERS | 421 | Q8WXA9 | |
| RERLERERMHVEHER | 666 | Q15424 | |
| RERMHVEHERRREQE | 671 | Q15424 | |
| VEHERRREQERIHRE | 676 | Q15424 | |
| LRHRRKHDDDRRFTC | 376 | Q2QGD7 | |
| RHEEEHRRREEEMIR | 351 | Q8WXF1 | |
| HRRREEEMIRHREQE | 356 | Q8WXF1 | |
| GHSRDREKRERERQE | 201 | Q96QK1 | |
| ERHWDSRTRDRDHDR | 191 | Q16560 | |
| SRTRDRDHDRGREKR | 196 | Q16560 | |
| ERDEIRHDRRKERQH | 351 | Q13573 | |
| HRDFKRDRETHRDRD | 1706 | P49750 | |
| RDRETHRDRDRDRGV | 1711 | P49750 | |
| CESRRRKERDGERHH | 316 | Q6IEG0 |